Clinical trial · Observational
Integrated Care Pathway in Oncology (PASSION)
Integrated Management of Care Pathway in Oncology. Impact on the Delay of Therapeutic Management and the Satisfaction of Patients and Carers
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...). The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit. The second aim is to assess the satisfaction of patients and health care teams.
Conditions
Conditions (8)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
| Thoracic Neoplasms | Thoracic Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Care pathway unit | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Historic cohort
- description
- Retrospective cohort of patients that were treated in the Hôpital Européen Georges Pompidou before the creation of the care pathway unit.
- label
- Prospective cohort
- description
- All consecutive patients that meet the inclusion criterion and will begin a cancer care after the study start.
- interventionNames
- Behavioral: Care pathway unit
Primary outcomes (1)
- measure
- Time between the first appointment with the oncologist and the beginning of antitumoral treatment.
- timeFrame
- 6 months
- description
- Delay of health care
Secondary outcomes (3)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven : colon, gastric, pancreatic, prostate, bladder, breast, thoracic, or ovarian cancer * First appointment for cancer care at the Hôpital Européen Georges Pompidou * Intravenous antitumoral treatment Exclusion Criteria: * Medical care non covered by social welfare * Radiochemotherapy * Death in the 6 months following first oncological appointment or absence of medical care in the year following the first oncological appointment
References
Publications (0)
Data not yet available